Purchase Order W81K0018P0665
- Not listed
- The U.S. Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $14,000.00 contract is for the delivery of 4 units of the NETSPOT (Gallium Ga 68 DOTATATE) unit dose product. The award does not have a small business set-aside designation. Advanced Accelerator Applications USA Inc. is a subsidiary of Novartis and...
- This is a $145,800 firm fixed price purchase order awarded by the Defense Health Agency to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, for the provision of NETSPOT Gallium 68 Injection Kits. The contract does not have a small business set-aside designation. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that develops, produces, and commercializes diagnostic and therapeutic nuclear medicine products. They have received numerous...
- This is a federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the supply of NETSPOT (GA-68 DOTATE) UNIT DOSE, a critical radiopharmaceutical product used in cancer treatment and diagnostic imaging. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price of $7,000.00 and a...
- This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a radiopharmaceutical company. The $325,439.69 firm fixed price purchase order is for the delivery of the radiopharmaceutical product Lutetium Lu 177 DOTATATE. The contract has a completion date of December 31, 2019 and was awarded on April 18, 2019. There is no set-aside designation for this award. Advanced Accelerator Applications USA Inc. is...
- This federal contract award was made by the Bureau of Medicine and Surgery, a defense agency, to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, valued at $14,000.00, is for the supply of NETSPOT (gallium-68), a radiopharmaceutical used in cancer treatment and diagnostic imaging. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price. It does not have a small...
- This federal contract award was made by the Defense Health Agency (DHA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $14,000.00. It is for the supply of NETSPOT (GA-68 DOTATATE) Unit Dose (4 EA), a radiopharmaceutical product used in cancer treatment and diagnostic imaging. The contract has a firm fixed price pricing...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary headquartered in Millburn, New Jersey, was awarded a firm fixed-price purchase order valued at $189,700 by the Defense Health Agency's Medical Command on January 1, 2021, for the supply of Gallium Ga-68 DOTATATE (NETSPOT) radiopharmaceutical injection kits to Tripler Army Medical Center in Hawaii. The contract was completed by September 30, 2022, with no small business set-aside designation. NETSPOT is a diagnostic...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 7 awarded a $140,700.00 firm fixed-price purchase order contract to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of NETSPOT GALLIUM 68 DOTATATE INJECTION, a radiopharmaceutical product, by the end of 2021. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that has...
- This is a $117,400.00 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceutical products. The contract is for the delivery of nuclear medicine products, including Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections, to VA medical centers and integrated service...
- This federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer, is for the delivery of the radiopharmaceutical product NETSPOT (gallium Ga 68 dotatate) to the U.S. Department of Veterans Affairs (VA). The award, with a ceiling value of $224,563.08, is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of September 30, 2025. This award is not set aside for small...
The Department of the Army Medical Command awarded a $760,000.00 firm fixed price purchase order contract to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of goods, to provide the radiopharmaceuticals Lutetium Lu 177 Dotatate and NETSPOT (Gallium Ga-68 Dotatate). This contract was not set aside for any small business category. The contract was awarded on October 1, 2018 with a completion date of September 30, 2019. The place of performance is New York, NY. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that specializes in targeted radioligand therapy and nuclear medicine, and has received prior federal contract awards from agencies such as the Department of Veterans Affairs, the Defense Health Agency, and the National Institutes of Health to provide these types of radiopharmaceutical products and services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NETSPOT and LUTHATHERA | W81K00-18-Q-0253 | Department of the Army Medical Command | Special Notice 2/2 | 8/13/18, 3:41 PM | |
FDA approved Gallium Ga-68 Dotatate and Lutetium Lu-177 Dotatate | W81K00-18-Q-0253 | Department of the Army Medical Command | Pre-Solicitation 1/2 | 8/6/18, 8:18 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Terminate for Convenience | ($1m) | 9/10/19 | |
| P00002 | Supplemental Agreement for work within scope | $329.0k | 5/15/19 | |
| P00001 | Funding Only Action | $1.7m | 12/28/18 | |
| Not listed | Not listed | $0 | 9/27/18 |